posted
Stem cells are got now the Democrats are in they should get the ball rolling low floater gets this thing going in a hurry!
Bio-Matrix Scientific Receives Certificate of Compliance for Class 10,000 Processing Laboratory:
Key points from the release:
1) announced today it has received its Certificate of Compliance for the new Stem Cell Class 10,000 Processing Laboratory
2) Bio-Matrix's stem cell processing laboratory now meets Federal Air Control Regulations to operate as a Class 10,000 Clean Room.
3) Bio-Matrix Chairman & CEO David Koos stated, "This certificate of compliance, which forms part of our comprehensive cGMP (good manufacturing practices) and cGTP (good tissue practices) systems, will assure our customers that their stem cells are processed and stored under safe, controlled environments."
4) Bio-Matrix's new 15,000-sq-ft, state-of-the-art laboratory, located in the heart of the San Diego biotechnology corridor, will house Bio-Matrix's secure Cryogenic Stem Cell Bank; three research laboratories; an aseptic cellular/tissue class 10,000/100 processing laboratory; and hematology, microbiology and flow cytometry laboratories.
5) Bio-Matrix Scientific Group Inc. (www.BMSNonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.
The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.
-------------------- Love 'em or Leave 'em either way I already did it.
IP: Logged |
Bio-Matrix Scientific to Attend the International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies Nov 20, 2006 8:30:00 AM Copyright Business Wire 2006 SAN DIEGO--(BUSINESS WIRE)--
Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today that they will be attending the 14th International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies in Las Vegas from December 7-10, 2006.
This is the largest Anti-Aging congress in the United States and this year's event is anticipated to draw over 6,000 participants and 70 plus international speakers. By limiting illness and disability in the latter stages of life, anti-aging medicine can make a quantum leap in people's enjoyment of their later years. This forum will allow companies to seek the latest cutting edge diagnostic and treatment technologies in the competitive medicine arena.
Bio-Matrix will have the opportunity to introduce our medical devices and cryogenic services to Physicians from every Medical Discipline, scientists and pharmaceutical companies. Bio-Matrix will also introduce its new 15,000 sq. ft. state-of-the-art secure Cryogenic Stem Cell Bank, three Research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.
This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN*agoracom.com, where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.
About Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific Group, Inc. (www.BMSNonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.
The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation, and is building a state-of-the-art facility in San Diego, Calif., to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.
DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Source: Bio-Matrix Scientific Group, Inc.
---------------------------------------------- Bio-Matrix Scientific Group Inc. Investor Relations 619-398-3517 info*BMSNonline.com or AGORA Investor Relations BMSN*agoracom.com http://www.agoracom.com/IR/Bio-Matrix
-------------------- Love 'em or Leave 'em either way I already did it.
IP: Logged |
posted
Hathaway is expected to register significant inorganic growth as it plans to acquire two to three companies every year. "We're currently looking at two other acquisitions in the telecommunications sector in both South America and the South Pacific," stated Mr. Paul D. Lisenby, acting CEO of Hathaway." stated Mr. Paul D. Lisenby, acting CEO of Hathaway.
OptiCon is expected to generate revenue to the tune of $250 million by 2008. According to a recent study conducted by Fiber Optics Weekly, the market for fiber optic equipment and systems is likely to increase dramatically by 10.3% per year through 2006. It is expected to reach a sizeable market of $22 billion in the near future. Furthermore, it is expected that 50% of all U.S. households will opt for broadband access by the year-end.
Hathaway Corporation announced that they have completed the acquisition of Diabetes Detection, Inc., for 3.1 million shares of Hathaway restricted common stock. Diabetes Detection, Inc. owns the exclusive license for the patent pending Vibrameter, which utilizes current hand-held communication devices for use in the early detection of diabetes.
According to government studies, early detection can reduce this number by $2.8 billion and devices such as the Vibrameter can test for early symptoms of this disease. Diabetes Detections Inc. is expected to generate revenue in the range of $150 million by 2008.
"Our wholly owned subsidiary, OptiCon Systems Inc, is in the final stages of the spin-off and Diabetes Detections Device Inc. (DDI) has a complete working prototype of the Vibrameter and is ready to begin clinical trial testing. The interest for this medical device has increased dramatically and we've had many conversations with several mobile device manufacturers for possible joint ventures." stated Mr. Paul D. Lisenby, acting CEO of Hathaway.
Opticon Systems, inc. was acquired by Hathaway Global on August 1st, 2005. Opticon Systems brings with it a software application acquired from Corning Cable Systems, inc. Hathaway Corporation announced that its wholly owned subsidiary, Diabetes Detections, Inc has entered into an alliance agreement with Research In Motion under RIM's BlackBerry(R) ISV Alliance Program.
Hathaway Corporation announced on June 6, 2006, the filing of an international patent on "METHOD AND COMBINATION ELECTRONIC COMMUNICATION AND MEDICAL DIAGNOSTIC APPARATUS FOR DETECTING/MONITORING NEUROPATHY" for Diabetes Detection, Inc. (DDI). The patents are currently being filed in Canada, China (including HK), Europe, India, Japan and South Korea.
-------------------- Love 'em or Leave 'em either way I already did it.
IP: Logged |
posted
News out looking very strong, should be interesting the more the Democrats get done in the Stem Cell Arena!
Bio-Matrix Scientific Enters into Validation and Protocol Process Nov 28, 2006 8:00:00 AM Copyright Business Wire 2006 SAN DIEGO--(BUSINESS WIRE)--
Bio-Matrix Scientific Group Inc. (OTCBB: BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today that it has entered into the facility validation process. This process focuses on the validation of systems and equipment involved in the manufacturing of both medical devices and cellular products.
Led by the Company's Chief Scientific Advisor, Dr. Geoffrey O'Neill, Bio-Matrix will develop its facility validation protocols. These protocols form an integral part of Bio-Matrix's Quality System that will comprise its overall Good Manufacturing and Good Tissue Practices (cGMP/cGTP).
Dr. O'Neill noted, "The management of Bio-Matrix has already developed the essential elements of its Quality System, including areas such as its quality policy, management responsibility and quality assessments. The validation process will specifically address procedures to ensure that all equipment and processes provide a quality product and that personnel are trained accordingly. Standard procedures will be developed for medical device production as well as for cellular processing and storage."
Chairman David Koos stated, "The installation, operational and performance qualification (IQ/OQ) of equipment, systems, facilities, and processes for cryogenics, processing, labs and medical devices are an essential part of the validation process. Equipment must be installed, operated, and maintained within design specifications, while processes must be shown to be reliable, all of which to assure the consistent quality and integrity of the product."
According to COO Brian Pockett, "Key staff must provide a basic and thorough understanding in preparing, executing and reviewing protocols. Management has the responsibility for approving and implements these protocols within the framework of its overall quality system."
Once protocols are completed, all Quality Systems documentation will be warehoused in the Company's Regulatory Affairs Department within the facility.
Bio-Matrix's new 15,000 sq ft state-of-the-art facility is located in the heart of the San Diego biotechnology corridor and will house Bio-Matrix's secure Cryogenic Stem Cell Bank, 3 Research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.
This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN*agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.
About Bio-Matrix Scientific Group Inc.
Bio-Matrix Scientific Group Inc. (www.BMSNonline.com), is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.
The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in the Biotechnology Corridor of San Diego, California, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.
DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Source: Bio-Matrix Scientific Group Inc.
---------------------------------------------- Bio-Matrix Scientific Group Inc. Investor Relations 619-398-3517 info*BMSNonline.com or AGORA Investor Relations BMSN*agoracom.com http://www.agoracom.com/IR/Bio-Matrix
-------------------- Love 'em or Leave 'em either way I already did it.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
